Depo-Medrol on Psoas After LLIF

Recruiting Phase 4 Interventional Study
Muscle Weakness Pain, Postoperative Paresthesia Pain, Muscle
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Other
Participants needed
80 (estimated)
Sponsor
Hardeep Singh · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The goal of this study is to determine the effects of a corticosteroid administered to the psoas muscle following a transpsoas lateral lumbar interbody fusion (LLIF) on postoperative hip flexor weakness and thigh pain and numbness.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients from the practices of Drs. Singh, Mallozzi, Moss * Transpsoas (PTP or LTP) lateral lumbar interbody fusion (LLIF) 1-3 disc levels with posterior instrumentation (Open or MIS) with or without laminectomy, must include L3-4 and/or L4-5 * Patients who agree to be a part …
Contacts

Hardeep Singh, MD

860-679-6883

uconnorthopaedics@uchc.edu

CONTACT

Study Coordinator

860-679-6883

uconnorthopaedics@uchc.edu

CONTACT